Ukrainian Pharma Firm BaDM Allocates 200 Million Hryvnias for Military and Hospital Aid in 2025.

BaDM's Charitable Initiatives

According to TSN.ua: BaDM, a leading pharmaceutical supplier in Ukraine, has directed significant funds through its charitable aid programs. In 2025, the company provided nearly 200 million hryvnias to support Ukraine's Armed Forces and hospitals, highlighting the critical need for a systematic, long-term approach to healthcare support rather than one-off solutions. This commitment is part of a broader effort by Ukrainian businesses to sustain the nation's resilience.

Investing in Medical Infrastructure

In 2025, BaDM allocated 81 million hryvnias for charitable purposes. Of this sum, nearly 12 million hryvnias was directed to support around fifty medical institutions, demonstrating the wide scope of its assistance. Since the start of the full-scale invasion, the company has provided approximately 40 million hryvnias in aid to over 140 healthcare facilities. The 'Pharmforce' project, launched in 2023, is another key part of its charitable work, through which 150,000 packages of medicine worth nearly 10 million hryvnias have been delivered.

In 2025, BaDM also provided aid worth about 8 million hryvnias to Dnipro City Clinical Hospital No. 4 and the Kyiv Regional Oncology Center. Doctors have noted that

"the donated medications positively influence the course of primary treatment during hospital stays"

Dmytro Babenko, a company representative, emphasized:

"For us, it is fundamentally important not just to hand over medicines, but to ensure continuity of therapy and support citizens' access to proper medical care."

In 2026, the company also plans to continue its charitable activities by providing antidepressants and sedatives for patients with severe illnesses. BaDM has been operating in the market for over 30 years, and its philanthropic efforts highlight the importance of corporate social responsibility during times of crisis.

BaDM's charitable work demonstrates a substantial contribution to supporting Ukraine's medical infrastructure, especially under wartime conditions. It not only supplies hospitals with essential medicines but also stresses the importance of continuous therapy for patients. The company's plans for 2026 indicate an intent to continue this vital work, reinforcing the role of business in social responsibility and supporting the nation's healthcare system.